Amidst volatility during quarter, economic data has become difficult to assess as consumers and businesses grapple with ...

Raludotatug deruxtecan (R-DXd) has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with platinum-resistant ...